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A bs tr ac t
Background
Previous studies have suggested a reduction in the total number of hospital admis-
sions for acute coronary syndrome after the enactment of legislation banning smok-
ing in public places. However, it is unknown whether the reduction in admissions 
involved nonsmokers, smokers, or both.
Methods
Since the end of March 2006, smoking has been prohibited by law in all enclosed 
public places throughout Scotland. We collected information prospectively on smok-
ing status and exposure to secondhand smoke based on questionnaires and bio-
chemical findings from all patients admitted with acute coronary syndrome to nine 
Scottish hospitals during the 10-month period preceding the passage of the legisla-
tion and during the same period the next year. These hospitals accounted for 64% 
of admissions for acute coronary syndrome in Scotland, which has a population of 
5.1 million.
Results
Overall, the number of admissions for acute coronary syndrome decreased from 
3235 to 2684 — a 17% reduction (95% confidence interval, 16 to 18) — as compared 
with a 4% reduction in England (which has no such legislation) during the same pe-
riod and a mean annual decrease of 3% (maximum decrease, 9%) in Scotland dur-
ing the decade preceding the study. The reduction in the number of admissions was 
not due to an increase in the number of deaths of patients with acute coronary syn-
drome who were not admitted to the hospital; this latter number decreased by 6%. 
There was a 14% reduction in the number of admissions for acute coronary syndrome 
among smokers, a 19% reduction among former smokers, and a 21% reduction 
among persons who had never smoked. Persons who had never smoked reported a 
decrease in the weekly duration of exposure to secondhand smoke (P<0.001 by the 
chi-square test for trend) that was confirmed by a decrease in their geometric mean 
concentration of serum cotinine from 0.68 to 0.56 ng per milliliter (P<0.001 by 
the t-test).
Conclusions
The number of admissions for acute coronary syndrome decreased after the imple-
mentation of smoke-free legislation. A total of 67% of the decrease involved non-
smokers. However, fewer admissions among smokers also contributed to the over-
all reduction.
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The smoking, health and social care Act, which was passed in 2005, prohibited smoking in all enclosed public places and 
workplaces in Scotland after the end of March 
2006. Smoke-free legislation aims to protect non-
smokers from secondhand smoke, but it may also 
reduce the risk among smokers because of re-
duced smoking or increased smoking cessation.1-4 
Eight studies have shown reduced numbers of 
hospital admissions for acute coronary syndrome 
after the enactment of such legislation.5-12 These 
studies were limited by retrospective data collec-
tion,5-12 the use of clinical diagnostic labels,5-12 
confounding by seasonal variations,7 and small 
numbers of patients.5,8,12 Only one study, involv-
ing 22 patients, included information on smok-
ing status,12 and none included information on 
exposure to secondhand smoke. Therefore, the in-
vestigators were unable to show the extent to which 
the overall reduction in hospital admissions was 
due to protection from secondhand smoke. Our 
aim was to prospectively compare the number of 
admissions for acute coronary syndrome before 
and after implementation of national legislation, 
overall and according to smoking status.
Me thods
Setting
Scotland has a population of 5.1 million. We col-
lected data prospectively on all patients with 
acute coronary syndrome admitted to nine hospi-
tals during the 10 months before implementation 
of the legislation (June 2005 through March 2006) 
and during the same 10 months thereafter (June 
2006 through March 2007). The hospital catch-
ment areas did not change; these areas accounted 
for 63% of admissions for acute coronary syndrome 
in Scotland before the legislation and 64% of these 
admissions after the legislation.13 We compared 
two periods involving the same months of the year 
to rule out seasonal effects, and we examined the 
change in hospital admissions by month to ensure 
that the change was not due to an atypically hot 
or cold month.
Case Ascertainment
The West Glasgow Research Ethics Committee 
approved the study, including access to case notes 
and specimens obtained from patients who died 
before recruitment. Acute coronary syndrome was 
defined as a detectable level of cardiac troponin 
after an emergency admission for chest pain. Dur-
ing the study periods, the troponin level was mea-
sured routinely in all patients admitted with chest 
pain. Therefore, our case definition could be ap-
plied consistently across all hospitals and patients, 
irrespective of day or time of admission or the unit 
to which the patient was admitted. To ensure com-
plete case ascertainment, the hospital laborato-
ries produced daily lists of troponin assays in pa-
tients who underwent those tests. Research nurses 
who were dedicated to the study identified all eli-
gible patients and conducted structured interviews. 
Written, informed consent was obtained from all 
patients.
Smoking Status and Exposure to Secondhand 
Smoke 
The level of cotinine was measured in residual se-
rum from clinical samples obtained on admission. 
All samples were centrifuged and stored locally 
at –20°C and then transported on dry ice to a cen-
tral laboratory (ABS Laboratory, London), where 
cotinine was assayed with the use of gas chroma-
tography with a specific nitrogen phosphorus 
detector.14 Cotinine and the internal standard 
5-methyl cotinine were extracted with the use of 
dichloroethane from 100-μl samples after alkal-
ization with the use of sodium hydroxide. The 
lower limit of detection was 0.1 ng per milliliter. 
Cotinine assays were used to validate self-report-
ed smoking status and provide an objective mea-
surement of exposure to secondhand smoke. Cur-
rent smokers were defined as persons who classified 
themselves as being smokers and persons with a 
serum cotinine level of more than 12 ng per mil-
liliter. Persons who had never smoked were de-
fined as persons who classified themselves as never 
having smoked and persons with a cotinine level 
of 12 ng per milliliter or less. Former smokers were 
defined as persons who classified themselves as 
being former smokers and persons with cotinine 
levels of 12 ng per milliliter or less. Nonsmokers 
comprised former smokers and persons who had 
never smoked.
Historical and Geographic Comparisons
To account for unrelated lifestyle or treatment 
changes, we studied the historical trend in Scot-
land and contemporaneous data from England, 
which is similar with regard to demographic pro-
file, lifestyle, climate, and free health care. The 
Scottish Morbidity Record 01 routinely collects in-
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formation on all hospital admissions, including 
the date and type of admission and disease codes.15 
We used these data to determine trends in admis-
sions for acute coronary syndrome (International 
Classification of Diseases, 10th revision [ICD-10], code 
I21) in the preceding 10 years. Hospital Episode 
Statistics collects similar information in England, 
where legislation banning smoking in public 
places was not implemented until July 2007.16 We 
used admissions for acute coronary syndrome 
(ICD-10 code I21) in England during the periods 
June 2005 through March 2006 and June 2006 
through March 2007 as a geographic control. The 
General Registrar’s Office for Scotland collates 
all death-certificate data, including date, place, 
and cause of death.17 We used these data to deter-
mine whether changes in the number of admis-
sions could be explained by changes in the number 
of patients who died without being hospitalized.
Statistical Analysis
We analyzed the percentage reduction in the num-
ber of admissions, overall and according to smok-
ing status, and we performed subgroup analyses 
according to the patients’ sex and age group. We 
analyzed two groups of admissions: the first group 
included men 55 years of age or younger and wom-
en 65 years of age or younger, and the second 
group included older patients. Since the denomi-
nators for these reductions in admissions were ran-
dom quantities, confidence intervals were derived 
from confidence intervals for the percentage of 
admissions during the two periods that occurred 
after enactment of the legislation. Assuming that 
the numbers of events before (Npre) and after (Npost) 
legislation are Poisson random variables, the re-
sult of the equation Npost divided by the sum of 
Npost and Npre will follow a binomial distribution. 
Transformation to an odds scale results in a con-
fidence interval for Npost divided by Npre, from which 
a confidence interval for the percentage reduction 
can be derived.
In the absence of catchment-population de-
nominators for subgroups of patients categorized 
according to smoking status, we were unable to 
determine a change in incidence. However, any 
population change would comprise a reduction in 
the number of smokers and an increase in the 
number of former smokers. Therefore, among for-
mer smokers, a reduction in the number of ad-
missions will underestimate a reduction in inci-
dence. Smoke-free legislation may reduce the 
prevalence of smoking in a population or the num-
ber of cigarettes smoked, but it will not alter the 
relative risk associated with smoking a given num-
ber of cigarettes. Among smokers, a decrease in 
prevalence would reduce the number of admis-
sions but have no effect on incidence, and there-
fore, a change in the number of admissions is 
more meaningful than population-based inci-
dence. The prevalence of smoking in a population 
of persons who had never smoked is unlikely to 
change in 1 year among patients in the age group 
at risk for acute coronary syndrome, since smok-
ing usually commences at a much earlier age. 
Therefore, among persons who had never smoked, 
the percentage reduction in the numbers of cases 
of acute coronary syndrome will equate to the per-
centage reduction in the incidence of acute coro-
nary syndrome.
Binary and ordinal data were compared with 
the use of chi-square tests and tests for trend, re-
spectively. We applied two-sample t-tests to loga-
rithmically transformed data on cotinine levels. 
Analyses were performed with the use of SPSS 
software for Windows, version 13.0 (SPSS).
R esult s
Admissions for Acute Coronary Syndrome
Before enactment of the legislation banning smok-
ing from public places, 3235 patients were admit-
ted to the hospital for acute coronary syndrome. 
After enactment of the legislation, this number 
decreased by 17% (95% confidence interval [CI], 
16 to 18), to 2684. The number of monthly ad-
missions during the whole period decreased; this 
decrease became more pronounced over time after 
the implementation of the legislation (P = 0.02 
by the chi-square test for trend) (Fig. 1). In England, 
the number of admissions for acute coronary syn-
drome decreased by 4% during a similar period. 
In Scotland, the trend during the 10 years before 
legislation was a 3% mean annual reduction 
(95% CI, 3 to 4), with a maximum reduction of 
9% in 2000; this reduction could not be attributed 
to the number of patients who were not hospital-
ized and who died from acute coronary syn-
drome. The number of patients who were not 
hospitalized and who died from acute coronary 
syndrome decreased by 6%, from 2202 patients 
during the period 2005 through 2006 to 2080 
patients during the period 2006 through 2007.
Of the 3235 patients with acute coronary syn-
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drome admitted to the hospital before enactment 
of the legislation, 2806 (87%) provided written 
informed consent to participate in the study, 252 
(8%) were unable to provide written informed con-
sent, and 177 (5%) declined to participate. Of the 
2684 patients with acute coronary syndrome ad-
mitted to the hospital after enactment of the legis-
lation, 2322 (87%) consented, 207 (8%) were un-
able to consent, and 155 (6%) declined. Therefore, 
the same percentage of patients provided informa-
tion during both periods (P = 0.80 by the chi-square 
test). Among smokers, the number of admissions 
decreased by 14% (95% CI, 12 to 16), from 1176 to 
1016. The number of admissions among former 
smokers decreased from 953 to 769 (19%; 95% CI, 
17 to 21), and the number of admissions among 
persons who had never smoked decreased from 
677 to 537 (21%; 95% CI, 18 to 24) (Table 1). There-
fore, 67% of the admissions prevented after the 
enactment of legislation involved nonsmokers.
Among current smokers, the reduction was 
greater among women (19%; 95% CI, 15 to 23) 
than among men (11%; 95% CI, 9 to 13) (Table 
1). Similarly, there was a greater decrease among 
women who were nonsmokers (23%; 95% CI, 20 
to 26) than among men who were nonsmokers 
(18%; 95% CI, 16 to 20). Among current smokers, 
the decrease was lower among men 55 years of age 
or younger and women 65 years of age or younger 
(9%; 95% CI, 6 to 12) than among older patients 
(18%; 95% CI, 15 to 21) (Table 1). The same was 
true for nonsmokers (8% [95% CI, 4 to 12], vs. 
22% [95% CI, 20 to 24]).
Exposure to Secondhand Smoke 
Among nonsmokers, 1614 (99%) provided infor-
mation on their exposure to secondhand smoke 
before enactment of the legislation, and 1285 
(98%) provided information about exposure after 
enactment. The correlation between cotinine and 
the self-reported duration of exposure to second-
hand smoke was similar before (r = 0.33, P<0.001) 
and after (r = 0.33, P<0.001) enactment of the leg-
islation. The percentage of persons who had never 
smoked who reported no exposure to secondhand 
smoke increased from 57% to 78% (P<0.001) (Ta-
ble 2), largely because of reduced exposure to 
smoke in pubs, bars, and clubs. The percentage 
of persons who reported no exposure to smoke 
in these locations increased from 77% to 96% 
(P<0.001) (Table 2). Self-reported reductions in ex-
posure to smoke were confirmed by a reduction 
in the geometric mean level of serum cotinine 
from 0.68 to 0.56 ng per milliliter (P<0.001). For-
mer smokers also reported reduced exposure to 
smoke (Table 2). The geometric mean level of co-
tinine in these persons decreased from 0.71 to 
0.57 ng per milliliter (P<0.001). Before the legis-
lation was enacted, men who were nonsmokers 
had the same geometric mean level of cotinine as 
women (i.e., 0.66 ng per milliliter). After the leg-
islation was enacted, this level decreased by 38%, 
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Figure 1. Admissions for Acute Coronary Syndrome According to Month before and after Smoke-free Legislation.
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to 0.41 ng per milliliter in men (P<0.001), and by 
47%, to 0.35 ng per milliliter in women (P<0.001). 
Among the admissions for acute coronary syn-
drome involving men 55 years of age or younger 
and women 65 years of age or younger, the geo-
metric mean level of cotinine decreased 34%, from 
0.90 to 0.59 ng per milliliter (P<0.001). Among 
older patients, it decreased 42%, from 0.62 to 
0.36 ng per milliliter (P<0001).
Overall, cotinine concentrations decreased less 
among patients with acute coronary syndrome 
than among persons in the general population. 
Among nonsmokers with acute coronary syn-
drome, the geometric mean level of serum coti-
nine decreased 18%, from 0.68 to 0.56 ng per 
milliliter. Among nonsmokers 45 years of age or 
older in the general population, the geometric 
mean level of cotinine in saliva was lower in both 
Table 2. Self-Reported Hours of Exposure to Secondhand Smoke per Week According to Location among Former 
Smokers and Persons Who Never Smoked.
Location and No.  
of Hours Former Smokers Persons Who Never Smoked 
Before 
Legislation 
(N = 937)
After Legislation 
(N = 748) P Value*
Before 
Legislation
(N = 677)
After Legislation 
(N = 537) P Value*
no. (%) no. (%)
Own home
0 hr 778 (83) 635 (85) 0.39 565 (83) 460 (86) 0.64
1–5 hr 71 (8) 48 (6) 41 (6) 18 (3)
≥6 hr 88 (9) 65 (9) 71 (10) 59 (11)
Other people’s homes
0 hr 860 (92) 698 (93) 0.42 617 (91) 495 (92) 0.34
1–5 hr 64 (7) 38 (5) 34 (5) 28 (5)
≥6 hr 13 (1) 12 (2) 26 (4) 14 (3)
Work
0 hr 902 (96) 740 (99) <0.001 640 (95) 519 (97) 0.04
1–5 hr 21 (2) 6 (1) 15 (2) 5 (1)
≥6 hr 14 (1) 2 (0) 22 (3) 10 (2)
Pubs, bars, or clubs
0 hr 709 (76) 737 (99) <0.001 522 (77) 515 (96) <0.001
1–5 hr 174 (19) 4 (1) 107 (16) 8 (1)
≥6 hr 54 (6) 7 (1) 48 (7) 14 (3)
Cars, buses, or trains
0 hr 918 (98) 733 (98) 0.74 644 (95) 519 (97) 0.33
1–5 hr 14 (1) 13 (2) 32 (5) 18 (3)
≥6 hr 5 (1) 2 (0) 1 (0) 0 (0)
Other public places
0 hr 826 (88) 733 (98) <0.001 579 (86) 518 (96) <0.001
1–5 hr 91 (10) 15 (2) 66 (10) 8 (1)
≥6 hr 20 (2) 0 (0) 32 (5) 11 (2)
All locations 
0 hr 489 (52) 589 (79) <0.001 385 (57) 418 (78) <0.001
1–5 hr 231 (25) 89 (12) 177 (26) 49 (9)
≥6 hr 217 (23) 70 (9) 115 (17) 70 (13)
* P values were calculated using the chi-square test for trend.
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periods but decreased by 42%, from 0.43 to 0.25 
ng per milliliter.14 The percentage of people with 
a cotinine concentration of more than 0.7 ng per 
milliliter decreased more among patients with 
acute coronary syndrome (from 42% to 9%, 
P<0.001) than among persons in the general popu-
lation (from 35% to 26%, P = 0.02).
Among smokers admitted to the hospital be-
cause of acute coronary syndrome, there was no 
significant reduction in the self-reported number 
of cigarettes smoked or the geometric mean level 
of cotinine (from 152 to 147 ng per milliliter; 
P = 0.72); the cotinine level among smokers in the 
general population decreased from 167 to 103 ng 
per milliliter.18
Discussion
We found a 17% reduction in the number of hos-
pital admissions for acute coronary syndrome af-
ter enactment of smoke-free legislation; this re-
duction was greater than the underlying trend and 
the contemporaneous change in a neighboring 
country without such legislation. The number of 
prevented admissions involving nonsmokers ac-
counted for 67% of the reduction.
Early compliance with the Scottish legislation 
was high.19 Two weeks after implementation of 
this legislation, the levels of secondhand smoke 
in bars had decreased by 86%. Concerns about 
displacement of smoking from public places into 
homes have not been realized. The results of co-
tinine assays in schoolchildren20 and adults who 
are nonsmokers18 have confirmed a reduced over-
all exposure to smoke. In the adult population of 
nonsmokers in Scotland, cotinine concentrations 
have decreased by 42%, similar to the 47% reduc-
tion after the enactment of smoke-free legislation 
in New York.21 In our study, nonsmokers with 
acute coronary syndrome who were admitted to 
hospitals had higher cotinine concentrations than 
persons in the general population; these findings 
are consistent with secondhand smoke being a 
risk factor for acute coronary syndrome. Our dif-
ference is an underestimate, since the level of coti-
nine was measured in serum and saliva, and the 
values from saliva specimens are 25% higher than 
those from serum.22 The decrease in the cotinine 
concentration among nonsmokers with acute coro-
nary syndrome who were admitted to the hospi-
tal was less than that in the general population; 
this finding is consistent with admissions being 
prevented through the protection of persons who 
were previously exposed to secondhand smoke. 
The percentage of nonsmokers with very high 
cotinine concentrations decreased more among 
persons who were admitted to the hospital than 
among the general population, suggesting that 
the number of events prevented among persons 
with a very high exposure to smoke before the 
enactment of the legislation was disproportion-
ately high.
The excess risk of acute coronary syndrome 
associated with smoking decreases within days 
after smoking cessation, and it is reduced by 50% 
at 1 year.23,24 The primary aim of smoke-free leg-
islation is to protect nonsmokers from second-
hand smoke. However, studies in other countries 
suggest that anticipation of legislation also en-
courages reduced smoking and cessation among 
smokers.1-4,24,25 In the 3 months before the en-
actment of the legislation in Scotland, the number 
of telephone calls to smoking-cessation services 
was 67% higher than it was in the subsequent 
3 months.26 The lack of reduced cotinine concen-
trations among smokers who were admitted to 
the hospital is not surprising, since admissions 
were prevented among persons who reduced the 
number of cigarettes smoked. These smokers con-
tribute to a decrease in the cotinine concentra-
tion in the population but not to the decrease in 
the number of hospital admissions.
One Italian study suggests reductions in acute 
coronary syndrome among persons 60 years of 
age or younger, but not among older patients.7 
A subsequent Italian study reported reductions 
in both age groups.10 In Scotland, we observed 
an 8% reduction (95% CI, 6 to 10) in acute coro-
nary syndrome among men who were 55 years 
of age or younger and women 65 years of age or 
younger as compared with a 20% reduction (95% 
CI, 18 to 22) in admissions involving men who 
were older than 55 years of age and women who 
were older than 65 years of age. The age effect 
was apparent among both smokers and nonsmok-
ers. Among nonsmokers, younger patients had a 
higher baseline cotinine concentration but a simi-
lar reduction in acute coronary syndrome (38% vs. 
42%). Caution should be heeded in extrapolating 
the effects of age and sex to a population in an-
other country. Culture and climate may produce 
demographic differences in smoking patterns in 
the home, public places, and outdoor spaces.
Our study suggests that the reduction in acute 
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coronary syndrome among nonsmokers may be 
greater among women than among men. Expo-
sure to smoke may have decreased more among 
women; among nonsmokers, the cotinine concen-
tration decreased by 37% in men and 47% in 
women. Alternatively, a similar reduction in expo-
sure to secondhand smoke may produce a greater 
effect in women than in men. Acute coronary syn-
drome is caused by thrombus formation at the 
site of a disrupted atherosclerotic plaque. Plaque 
rupture is the most common cause of this syn-
drome, although thrombus formation on an erod-
ed plaque is particularly common in women.27 
Although some risk factors for acute coronary syn-
drome, such as dyslipidemia, predispose to plaque 
rupture, smoking increases the risk through acute 
thrombosis.28 Hence, the relative risk associat-
ed with smoking is greater among women than 
among men and is associated with a steeper dose 
response.29
Three studies have examined local legislation 
banning smoking in public places in geographi-
cally isolated communities. Sargent et al. showed 
a 40% reduction (95% CI, 1 to 79) in the number 
of hospital admissions for myocardial infarction 
among the 68,140 inhabitants of Helena, Montana, 
as compared with a nonsignificant increase in 
hospital admissions involving patients living out-
side Helena.5 This study comprised only 64 ad-
missions over 12 months. Pechacek and Babb 
suggested that a 40% reduction in hospital ad-
missions was implausible, and they calculated 19% 
as the theoretical maximum reduction achievable 
through a reduction in exposure to secondhand 
smoke.30 Khuder et al. showed a 39% reduction 
in hospital admissions after enactment of smoke-
free legislation in Bowling Green, Ohio, which 
has a population of less than 30,000.8 Among 
residents of Pueblo, Colorado, which has a popu-
lation of 148,000, the number of hospital admis-
sions for myocardial infarction decreased by 27%, 
as compared with a 15% decrease among non-
residents who were admitted to the same hospital 
and a 3% decrease in another city without such 
legislation.6
The number of admissions for acute coronary 
syndrome decreased by 13% after the enactment 
of smoke-free legislation in Saskatoon, SK, Cana-
da, which has a population of 220,00011; this find-
ing is concomitant with a 25% reduction in the 
prevalence of smoking (from 24% to 18%). A mod-
est 8% reduction in the prevalence of smoking 
occurred in New York because of local and par-
tial restrictions (i.e., restrictions in some public 
places but not in others) during the 8-year period 
before enactment of statewide smoke-free legis-
lation and because of an atypically low baseline 
level of exposure to smoke.9 The investigators esti-
mated that the reduction in prevalence would have 
been 19% if the local restrictions had not oc-
curred. Barone-Adesi et al. compared the number 
of hospital admissions for myocardial infarction 
before and after enactment of smoke-free legis-
lation in Piedmont, Italy, with the number of ad-
missions during the same periods in the previous 
year.7 The number of admissions decreased among 
patients who were 60 years of age or younger 
(odds ratio, 0.89; 95% CI, 0.81 to 0.98), but not 
among older patients. In Rome, which has a popu-
lation of 2.7 million, acute coronary events de-
creased by 7.9% among persons 65 to 74 years of 
age (95% CI, 3.4 to 12.2) and by 11.2% among 
younger patients (95% CI, 6.9 to 15.3).10
All studies to date were retrospective and used 
clinical diagnostic labels. The studies described 
above did not include information on smoking 
status or exposure to secondhand smoke, and the 
investigators were unable to determine whether 
the overall reduction in hospital admissions in-
volved nonsmokers or smokers. Only one previous 
study included information on smoking status. 
Seo and Torabi reported a 71% reduction in the 
number of admissions to Bloomington Hospital 
in Bloomington, Indiana, because of acute coro-
nary syndrome among self-reported nonsmokers, 
from 17 admissions during the 22-month period 
before the enactment of smoke-free legislation to 
5 admissions during the 22-month period after the 
legislation.12 There was a nonsignificant 11% re-
duction in admissions to a control hospital. There 
was no reduction in the number of admissions 
among smokers (8 vs. 7). The investigators were 
unable to corroborate self-reported smoking sta-
tus on the basis of biochemical tests.
A meta-analysis of four early studies reported 
a pooled relative-risk estimate of 0.73.31 Later stud-
ies have provided lower effect estimates, but the 
95% confidence intervals associated with the 
pooled estimate (0.56 to 0.89) nonetheless were 
consistent with the 17% overall reduction in hos-
pital admissions that we observed. Between-coun-
try differences are inevitable because of different 
levels of baseline exposure to smoke.
Our study has a number of strengths. The nine 
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hospitals served a population of more than 3 mil-
lion. We ascertained the number of admissions 
prospectively using a standard definition that in-
cluded confirmation based on biochemical tests. 
We linked our data to the Scottish Morbidity Re-
cord 01 database. Only 52% of our subjects re-
ceived a clinical diagnosis of ICD-10 code I21 
(acute myocardial infarction), with no difference 
in the diagnosis between the two study periods 
(1966 diagnoses [52%] vs. 1663 diagnoses [51%]). 
The remainder received uninformative codes: pre-
dominantly I251 (atherosclerotic disease), I200 
(unstable angina), R074 (chest pain, unspecified), 
and I248 (other forms of acute ischemic heart dis-
ease); these findings highlight the limitations of 
retrospective studies with the use of routine data. 
We had information on both the underlying trend 
before the study and the contemporaneous change 
in a neighboring country. We collected detailed 
information prospectively on smoking and expo-
sure to secondhand smoke using both question-
naires and biochemical assays.
Further studies are required to determine 
whether the early improvements will be sustained. 
Smokers who quit may subsequently relapse. Con-
versely, changing social attitudes may discourage 
young people from beginning to smoke, produc-
ing an additional benefit in the future. Our over-
all results are consistent with those of other stud-
ies. The World Health Organization’s Framework 
Convention on Tobacco Control is the first inter-
national legal treaty to focus on improving pub-
lic health.32 In Article 8, the signatories commit 
to protect the public from exposure to second-
hand smoke. Our findings provide support for the 
treaty.
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